These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 12370430)

  • 1. Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals.
    Ishida S; Lee J; Thiele DJ; Herskowitz I
    Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14298-302. PubMed ID: 12370430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low Ctr1p, due to lack of Sco1p results in lowered cisplatin uptake and mediates insensitivity of rho0 yeast to cisplatin.
    Bodiga S; Vemuri PK; Bodiga VL
    J Inorg Biochem; 2018 Oct; 187():14-24. PubMed ID: 30041154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The copper transporter CTR1 regulates cisplatin uptake in Saccharomyces cerevisiae.
    Lin X; Okuda T; Holzer A; Howell SB
    Mol Pharmacol; 2002 Nov; 62(5):1154-9. PubMed ID: 12391279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copper-dependent degradation of the Saccharomyces cerevisiae plasma membrane copper transporter Ctr1p in the apparent absence of endocytosis.
    Ooi CE; Rabinovich E; Dancis A; Bonifacino JS; Klausner RD
    EMBO J; 1996 Jul; 15(14):3515-23. PubMed ID: 8670854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A copper connection to the uptake of platinum anticancer drugs.
    Nitiss JL
    Proc Natl Acad Sci U S A; 2002 Oct; 99(22):13963-5. PubMed ID: 12391309
    [No Abstract]   [Full Text] [Related]  

  • 6. Relevance of copper transporter 1 for cisplatin resistance in human ovarian carcinoma cells.
    Kalayda GV; Wagner CH; Jaehde U
    J Inorg Biochem; 2012 Nov; 116():1-10. PubMed ID: 23010323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular pharmacology of cisplatin in relation to the expression of human copper transporter CTR1 in different pairs of cisplatin-sensitive and -resistant cells.
    Beretta GL; Gatti L; Tinelli S; Corna E; Colangelo D; Zunino F; Perego P
    Biochem Pharmacol; 2004 Jul; 68(2):283-91. PubMed ID: 15194000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Saccharomyces cerevisiae copper transport protein (Ctr1p). Biochemical characterization, regulation by copper, and physiologic role in copper uptake.
    Dancis A; Haile D; Yuan DS; Klausner RD
    J Biol Chem; 1994 Oct; 269(41):25660-7. PubMed ID: 7929270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct mechanisms for Ctr1-mediated copper and cisplatin transport.
    Sinani D; Adle DJ; Kim H; Lee J
    J Biol Chem; 2007 Sep; 282(37):26775-26785. PubMed ID: 17627943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the cellular pharmacology of JM118, the major metabolite of satraplatin, by copper influx and efflux transporters.
    Samimi G; Howell SB
    Cancer Chemother Pharmacol; 2006 Jun; 57(6):781-8. PubMed ID: 16170571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The copper transporter Ctr1 contributes to cisplatin uptake by renal tubular cells during cisplatin nephrotoxicity.
    Pabla N; Murphy RF; Liu K; Dong Z
    Am J Physiol Renal Physiol; 2009 Mar; 296(3):F505-11. PubMed ID: 19144690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of human copper transporter Ctr1 in the transport of platinum-based antitumor agents in cisplatin-sensitive and cisplatin-resistant cells.
    Song IS; Savaraj N; Siddik ZH; Liu P; Wei Y; Wu CJ; Kuo MT
    Mol Cancer Ther; 2004 Dec; 3(12):1543-9. PubMed ID: 15634647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copper deprivation modulates CTR1 and CUP1 expression and enhances cisplatin cytotoxicity in Saccharomyces cerevisiae.
    Kommuguri UN; Bodiga S; Sankuru S; Bodiga VL
    J Trace Elem Med Biol; 2012 Jan; 26(1):13-9. PubMed ID: 22365074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin enhances cisplatin sensitivity of human NSCLC cell lines through influencing Cu-Sp1-CTR1 regulatory loop.
    Zhang W; Shi H; Chen C; Ren K; Xu Y; Liu X; He L
    Phytomedicine; 2018 Sep; 48():51-61. PubMed ID: 30195880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copper ion-sensing transcription factor Mac1p post-translationally controls the degradation of its target gene product Ctr1p.
    Yonkovich J; McKenndry R; Shi X; Zhu Z
    J Biol Chem; 2002 Jul; 277(27):23981-4. PubMed ID: 12011036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Claudin-3 and claudin-4 regulate sensitivity to cisplatin by controlling expression of the copper and cisplatin influx transporter CTR1.
    Shang X; Lin X; Manorek G; Howell SB
    Mol Pharmacol; 2013 Jan; 83(1):85-94. PubMed ID: 23053666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A re-evaluation of the role of hCTR1, the human high-affinity copper transporter, in platinum-drug entry into human cells.
    Ivy KD; Kaplan JH
    Mol Pharmacol; 2013 Jun; 83(6):1237-46. PubMed ID: 23543413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of the major copper influx transporter CTR1 to the cellular accumulation of cisplatin, carboplatin, and oxaliplatin.
    Holzer AK; Manorek GH; Howell SB
    Mol Pharmacol; 2006 Oct; 70(4):1390-4. PubMed ID: 16847145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contributions of rat Ctr1 to the uptake and toxicity of copper and platinum anticancer drugs in dorsal root ganglion neurons.
    Liu JJ; Kim Y; Yan F; Ding Q; Ip V; Jong NN; Mercer JF; McKeage MJ
    Biochem Pharmacol; 2013 Jan; 85(2):207-15. PubMed ID: 23123662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The roles of copper transporters in cisplatin resistance.
    Kuo MT; Chen HH; Song IS; Savaraj N; Ishikawa T
    Cancer Metastasis Rev; 2007 Mar; 26(1):71-83. PubMed ID: 17318448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.